ALA-2000, a sustained release naltrexone injectable for alcohol use disorder or opioid use disorder
Category: Pharmaceutical
Exhibitor: ALAR PHARMACEUTICALS INC.
Booth No: M636
Characteristic
ALA-2000 is a long-acting injection for treating alcohol use disorder or opioid use disorder using Alar self-developed In-Relar sustained release drug delivery platform. Through steadily releasing therapeutic levels of naltrexone without dose dumping, ALA-2000 is anticipated to reduce the burden of drug administration, improving patients' medication adherence and convenience.
Other Products
Products you may be interested in
Highest Rated Products